Skip to main content
XTPL S.A. logo

XTPL S.A. — Investor Relations & Filings

Ticker · XTP ISIN · PLXTPL000018 LEI · 259400H9PEQYON2NI017 WAR Manufacturing
Open in API
Filings indexed 1,313 across all filing types
Latest filing 2024-05-22 Interim / Quarterly Rep…
Country PL Poland
Listing WAR XTP

About XTPL S.A.

https://xtpl.com/

XTPL S.A. is a deep-tech company that develops and commercializes a proprietary additive manufacturing technology for the ultra-precise printing of nanomaterials. Its core technology, Ultra-Precise Dispensing (UPD), enables the creation of conductive and non-conductive structures at the microscale, supporting the production of next-generation electronics. The company offers its solutions through industrial modules designed for integration into manufacturing lines and complete laboratory systems, such as the Delta Printing System, for prototyping and research. XTPL's technology is targeted at high-growth sectors including semiconductors, advanced packaging, displays, consumer electronics, HealthTech, and automotive, facilitating miniaturization and enhanced device functionality.

Recent filings

Filing Released Lang Actions
XTPL Sprawozdanie Finansowe za 1Q 2024
Interim / Quarterly Report Classification · 100% confidence The document is a 'Raport kwartalny' (Quarterly Report) for XTPL S.A. for the first quarter of 2024. It contains comprehensive financial data, management discussion and analysis, and consolidated financial statements for the period. It is not an announcement of a report, but the report itself, fitting the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-22 Polish
Udzielenie patentu przez Japoński Urząd Patentowy (JPO). - Content (EN)
Regulatory Filings Classification · 100% confidence The document reports on a specific legal/intellectual property event: the receipt of a patent issue notification from the Japan Patent Office (JPO) for a specific invention. This type of announcement, concerning intellectual property rights, legal milestones, or regulatory actions that impact the company's core assets, fits best under the 'Legal Proceedings Report' (LTR) category, as it details a significant legal/IP development. It is not a standard financial report (10-K, IR, ER), a management change (MANG), or a general regulatory filing (RNS). Given the content focuses on a patent grant, LTR is the most specific fit among the provided options, although 'RNS' could be a fallback if LTR was deemed too narrow. However, LTR covers legal matters, and patents are legal assets.
2024-05-17 English
Udzielenie patentu przez Japoński Urząd Patentowy (JPO). - Content (PL)
Regulatory Filings Classification · 100% confidence The document text is a formal announcement from the Management Board (Zarząd) of XTPL S.A. informing that they received notification from the Japanese Patent Office regarding the granting of a patent for an invention. This relates to intellectual property rights and strategic development. It is not an earnings release (ER), an annual report (10-K), a management discussion (MDA), or a dividend notice (DIV). Since it concerns a specific legal/IP event (patent grant) that impacts commercialization and investor perception, it is best classified as a specific regulatory or material event announcement. Given the options, it most closely aligns with an announcement regarding a significant development that might not fit standard financial reporting categories, but since it is a specific legal/IP event, and not a general regulatory filing fallback (RNS), I must check if there is a better fit. None of the specific codes (like LTR for legal proceedings) perfectly capture a patent grant. However, the content describes a material event impacting the company's technology and commercialization strategy, which is often disclosed via regulatory channels. Since it is a specific, material, non-financial announcement, and there is no dedicated 'Intellectual Property' code, I will evaluate if it fits 'Regulatory Filings' (RNS) as a catch-all for material non-financial news, or if it implies a change in capital structure (CAP) or management (MANG), which it does not. Given the nature of reporting material, non-financial, non-management events, RNS is the most appropriate fallback if a more specific code is unavailable. However, upon re-reviewing the definitions, the document is a direct announcement of a material event (patent grant) that is deemed inside information under MAR. This type of announcement is typically classified under general regulatory disclosures. I will use RNS as the most suitable general regulatory announcement category for this specific IP development.
2024-05-17 Polish
Zawarcie niewyłącznej umowy dystrybucji rozwiązań technologicznych Emitenta na terenie Francji. - Content (EN)
Regulatory Filings Classification · 95% confidence The document announces the signing of a non-exclusive distribution agreement under the legal basis of Article 17(1) MAR (Market Abuse Regulation), which mandates the immediate public disclosure of inside information. This type of announcement, detailing a significant business development (a new distribution agreement in France) that is deemed confidential until disclosure, is a form of regulatory disclosure concerning material corporate events. It is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a proxy statement (DEF 14A). Since it is a specific, material, non-financial regulatory announcement that doesn't fit the other specific categories like M&A (TAR) or Capital Change (CAP), it falls best under the general 'Regulatory Filings' category (RNS) as a mandatory disclosure of inside information.
2024-05-10 English
Zawarcie niewyłącznej umowy dystrybucji rozwiązań technologicznych Emitenta na terenie Francji. - Content (PL)
Regulatory Filings Classification · 95% confidence The document text describes the signing of a non-exclusive distribution agreement between XTPL S.A. and CDS ELECTRONIQUE for the distribution of XTPL's technological solutions in France. The text explicitly states that the Management Board considers this information to be inside information because its execution may significantly impact the issuer's future revenue situation and perception by investors, thus meeting the criteria of Article 7(1) of the MAR Regulation. This type of announcement, detailing a significant commercial contract or partnership that impacts future revenue, is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if it were about fundraising, but here it is a material commercial event announcement. Since there is no specific category for 'Material Commercial Contract Announcement' and it is a regulatory disclosure of material non-public information, RNS (Regulatory Filings) is the most appropriate fallback, as it is a general regulatory announcement that doesn't fit the other specific financial/governance categories. Given the content is a specific announcement of a material event, RNS is the best fit among the provided options for a non-standard regulatory disclosure.
2024-05-10 Polish
Uznanie ochrony patentowej przez Urząd Patentów i Znaków Towarowych Stanów Zjednoczonych (USPTO). - Content (EN)
Regulatory Filings Classification · 99% confidence The document reports a specific, material event: the allowance of a patent by the US Patent and Trademark Office. This information is being disclosed under Article 17(1) of MAR (Market Abuse Regulation), indicating it is confidential information that is now being made public. This type of announcement concerns a specific legal/intellectual property event that impacts the company's value and strategy. It is not an Annual Report (10-K), Earnings Release (ER), or a general management change (MANG). It is a specific regulatory disclosure regarding a legal/IP matter. While it relates to legal proceedings/IP, the most fitting general category for specific, material, non-financial regulatory disclosures that don't fit other specific codes (like DIV, DIRS, or MANG) is often the general Regulatory Filings category (RNS), or potentially Legal Proceedings Report (LTR) if the focus was on a lawsuit. Given the context of a patent allowance being treated as confidential MAR information, it functions as a material regulatory announcement. Since 'LTR' usually implies litigation or regulatory action *against* the company, and this is a positive IP development disclosed under MAR, 'RNS' (Regulatory Filings - the fallback for miscellaneous regulatory announcements) is the most appropriate fit among the provided options for a material, non-standard disclosure.
2024-05-09 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.